Atlas Trials

Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration

Clinical trial NCT05011474 · UNKNOWN

Trial details

NCT number
NCT05011474
Sponsor
Inbo Han
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Patients With Chronic Low Back Pain Due to Degenerative Lumbar Disc
Start date
2021-04-23
Primary completion
2022-01-20
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.